ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

KIDS OrthoPediatrics Corporation

31.09
-2.40 (-7.17%)
11 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
OrthoPediatrics Corporation NASDAQ:KIDS NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.40 -7.17% 31.09 12.51 35.00 33.75 30.75 33.75 151,611 00:56:26

OrthoPediatrics Corp. Launches New RESPONSE Rib and Pelvic Fixation System for EOS Scoliosis

04/03/2024 9:05pm

GlobeNewswire Inc.


OrthoPediatrics (NASDAQ:KIDS)
Historical Stock Chart


From Feb 2024 to May 2024

Click Here for more OrthoPediatrics Charts.

OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS a company focused exclusively on advancing the field of pediatric orthopedics, today announced it has launched a new RESPONSE™ Rib and Pelvic Fixation system to treat children with Early Onset Scoliosis (“EOS”). This represents the company’s 71st system to treat orthopedic conditions in pediatric patients.

This system represents OrthoPediatrics first solution to treat Early Onset Scoliosis patients, and specifically those associated with or at risk of Thoracic Insufficiency Syndrome. The new addition to the RESPONSE™ family includes implants and instruments for rib and pelvic fixation, and associated devices to connect the fixation points. The system also features a range of implant options, low profile implants, range of motion rib hooks, and locking options to keep implants in place. As an adjunct to the foundational RESPONSE™ Scoliosis System, the Rib and Pelvic system is compatible with 5.5/6.0 and 4.5/5.0 RESPONSE™ Systems, allowing surgeons to treat the entire spectrum of patients with scoliosis.

Greg Odle, President of the OrthoPediatrics’ Scoliosis Division echoed his excitement for the launch of this new system, saying “We are excited to enter the Early Onset Scoliosis treatment market with the RESPONSE™ Rib & Pelvic System. While this is our first treatment option in the EOS market, we continue to work with pediatric orthopedic surgeons to develop additional treatment options for EOS patients.”

About OrthoPediatrics Corp.Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 71 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com.

Investor ContactPhilip Trip Taylor Gilmartin Groupphilip@gilmartinir.com415-937-5406

1 Year OrthoPediatrics Chart

1 Year OrthoPediatrics Chart

1 Month OrthoPediatrics Chart

1 Month OrthoPediatrics Chart

Your Recent History

Delayed Upgrade Clock